ArticleJournal of central nervous system disease2022

Viloxazine for Attention-Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Alok Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.